Familial cancer Flashcards
Consultation of genetic conselling
- draw out family tree then verify diagnosis
- estimate likelihood of predisposing gene mutation
- discuss screening, risk facors and preventative meausures
- Test for mutations (e.g BRCA-1)
Patient History
Family: >1 individual in same family affected by similar cancer
Individual: multitude 1o tumours, early age of onset
Capability of cell to develop/ cancer
proliferating signalling
avoidance of apoptosis (loss p53)
by passing replicate senescence (inactivation of p53/ Rb signalling)
Insensitivty to anti-growth signalling (TGF-B signalling)
escape from immune surveillance (T-reg)
Control of cell cycle
Tumour supressor genes - 90
- inhibit progression through cell cycle (eg Rb, p53)
- promote apoptosis (p53) or act as stability genes (loss of funtion)
Stability genes- type of tumour supressor gene, minimise genetic alterations, when inactivated mutation in other genes more common
Proto-oncogenes
- stimulate progression
- activate- oncogenes with gain of function to result in cancerous proliferation
Familial cancer
Uncommon (5-10%)
early onset
multiple primary tumours
Single mutation in life
Sporadic
common (90-95%)
late onset
single primary tumour
Two mutations in life
- mostly inherited in AD fashion
Knudsons two hit hypothesis
require two mutations for disease to develop (tumour supressor gene)
Le Fraumeni Syndrome
Autosomal dominant
Mutation - TP53
Characteristic - earl onset, development of multiple cnacer
Tumour suppressor genes
BRAKES
Normal function
1. inhibit progression through the cell cycle and cell proliferation - RB, TP53, NF1, APC
2. promote apoptosis TP53, BAX or
3. Stability genes - MLH1, MSH2, BRCA1, BRCA2
Mutation results in loss of function of protein
Need 2 inactivet gene copies for tumourgenic effect of gene (second hit after inheritance of one inactivated copy)
where inherited, pedigree shows an autosomal dominant pattern of cancer predisposition with incomplete penetrance
Proto-oncogenes
Proto-oncogenes
Normal function
- stimulates the cell cycle or
- promtoe cell division.growth
Mutations
- not usually inherited Except RET gene - causes MEN2
- activated by mutation results in “oncogenes” - gain of function
- need 1 mutated gene copy for tumouregenic effect of gene
Breast cancer Genes
BRCA 1- chromosome 17
BRCA 2- chromosome 13
BRCA1 - 1/2 found in 84% of familiies that have had 4 people with breast cancer before 60 years old
Ovarian cancer increases the chances of BRCA1 Male breast cancer increases the chances of BRCA2
BRCA 1: 65% of breast cancer by 70 maybe 80 if modifier genes
40% of ovarian cancer
BRCA 2: 45% risk of breast cancer 11% risk of ovarian cancer 5-6% risk of male breast cancer
Other genetic mutations that can cause breast cancer
TP53 (Li fraumeni syndrome) PALB2
PTEN (thyroid and endometrial cancer)